Skip to main content
. 2020 Jun 29;9(7):2033. doi: 10.3390/jcm9072033

Table 4.

Management of hyperthyroidism induced by immune checkpoint inhibitors.

CTCAE Grade Management Treatment of Adverse Event
Grade 1
  • Continue ICI treatment

  • Continue to monitor TSH and FT4 levels until hyperthyroidism disappears

Grade 2
  • Stop ICI treatment until the symptoms ameliorate or test values become normal

  • After amelioration of symptoms, resume administration of ICI

  • Consult an endocrinologist

  • Perform a thyroid function test every 2–3 weeks

  • If the thyroid poisoning does not resolve after 6–8 weeks, Graves’ disease is differentiated

Grade 3 or 4
  • Same as above

  • Consult an endocrinologist

  • Start administration of β-blocker

  • Conduct clinical tests every 1–3 weeks

  • In case of thyroid crisis, treat the patient in the intensive care unit

CTCAE, Common Terminology Criteria for Adverse Events; ICI, immune checkpoint inhibitor; TSH, thyroid-stimulating hormone; FT4, free T4.